Adapting cervical cancer screening to decreasing HPV infection rates
July 12th 2021For cervical cancer screening, human papillomavirus (HPV)–based screening modalities detect significantly more abnormal cervical cells than traditional liquid-based cytology (LBC) approaches, according to a study in JAMA Network Open.
Inside the July issue of Contemporary OB/GYN®
July 12th 2021This month's cover story examines iron-deficiency anemia in pregnancy and the role of intravenous iron. Plus, an extreme case of fraud demonstrates the reach of federal statutes enacted to prevent and punish those who commit health care fraud.
Financial success and patient satisfaction: Are they related?
July 8th 2021When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.
Telemedicine for managing diabetes in pregnancy
July 8th 2021A significant uptick in telemedicine for managing diabetes in pregnancy occurred during the COVID-19 crisis, which should continue as the pandemic subsides, according to a session on telemedicine at the American Diabetes Association (ADA) virtual conference.
Novel antifungal treatment approved for vaginal candidiasis
July 7th 2021On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the Food and Drug Administration for vulvovaginal candidiasis (VVC) in adult women and pediatric females who have begun menstruating. Ibrexafungerp is a triterpenoid antifungal that works by inhibiting the formation of the fungal cell wall. Ibrexafungerp (pronounced eye-BREX-ah-FUN-jerp) is the first approved drug of a novel class of antifungals.
Ultrasound to predict placental pathology
July 5th 2021Despite the umbilical artery (UA) Doppler pulsatility index being used to detect elevated fetoplacental vascular resistance, the metric is confounded by variation in fetal cardiac function and is only moderately predictive of placental pathology.
Tools to use: ACOG’s payment advocacy and policy portal
July 2nd 2021Scott Kober hosts this podcast in which he interviews Lisa Satterfield, senior director of health economics and practice management at the American College of Obstetricians and Gynecologists (ACOG). They discuss the tools and resources available to practicing ob-gyns that are focused specifically on payer and reimbursement issues.
Sexual health education of ob-gyn resident physicians: How are we doing?
July 1st 2021To gauge progress that had been made in the decade since the establishment of CREOG, more than 4,000 U.S.-based ob-gyn residents were sent a 32-item survey in June 2016 to gauge their comfort level in asking patients about their sexual history and providing counseling to patients of varying ages and ethnic/racial backgrounds.
Bringing sexual dysfunction to the conversation for women with diabetes
June 29th 2021The management of diabetes is multifaceted, often requiring the collaboration of a multidisciplinary team of providers. While sexual side effects of diabetes are not commonly discussed during patient visits, there is a correlation between the presence of diabetes and frequent sexual dysfunction in women.
Does bacterial vaginosis increase risk of developing uterine fibroids?
June 24th 2021No evidence exists that bacterial vaginosis (BV)-associated bacteria increases the risk of developing uterine fibroids (UFs) or the number of UFs, according to a nested case-control study in the journal Sexually Transmitted Diseases.